• Je něco špatně v tomto záznamu ?

En bloc resection of bladder tumour: the rebirth of past through reminiscence

JY. Teoh, D. D'Andrea, A. Gallioli, T. Yanagisawa, S. MacLennan, R. Nicoletti, NC. Fai, D. Maffei, R. Hurle, L. Lusuardi, B. Malavaud, J. Miki, M. Kramer, H. Mostafid, D. Enikeev, M. Babjuk, A. Breda, S. Shariat, P. Gontero, T. Herrmann

. 2023 ; 41 (10) : 2599-2606. [pub] 20230816

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001160
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem

PURPOSE: To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer. METHODS: In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT. RESULTS: Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting. CONCLUSION: ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.

Academic Urology Unit University of Aberdeen Aberdeen UK

Department of Biomedical Sciences Humanitas University Milan Italy

Department of Surgery S H Ho Urology Centre The Chinese University of Hong Kong Hong Kong SAR China

Department of Urology 2nd Faculty of Medicine Hospital Motol Charles University Prague Czech Republic

Department of Urology and Andrology Salzburg University Hospital Paracelsus Medical University 5020 Salzburg Austria

Department of Urology Città Della Salute e Della Scienza University of Torino School of Medicine Turin Italy

Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria

Department of Urology Fundació Puigvert Autonoma University of Barcelona Barcelona Spain

Department of Urology IRCCS Humanitas Research Hospital Rozzano Italy

Department of Urology Kantonsspital Frauenfeld Frauenfeld Switzerland

Department of Urology The Jikei University School of Medicine Tokyo Japan

Department of Urology The Stokes Centre for Urology Royal Surrey Hospital Guildford UK

Department of Urology University College London Hospital NHS Foundation Trust London UK

Department of Urology University Hospital Schleswig Holstein Lübeck Germany

Department of Urology University of Texas Southwestern Dallas TX USA

Department of Urology Weill Cornell Medical College New York NY USA

Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman Jordan

Institut Universitaire du Cancer Toulouse Oncopôle Toulouse France

Institute for Urology and Reproductive Health Sechenov University Moscow Russia

Unit of Urological Robotic Surgery and Renal Transplantation Careggi Hospital University of Florence Florence Italy

Urothelial Cancer Working Group European Association of Urology Young Academic Urologists (EAU YAU Amsterdam Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001160
003      
CZ-PrNML
005      
20240213094411.0
007      
ta
008      
240109s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00345-023-04547-0 $2 doi
035    __
$a (PubMed)37584691
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Teoh, Jeremy Yuen-Chun $u Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China. jeremyteoh@surgery.cuhk.edu.hk $u Urothelial Cancer Working Group, European Association of Urology-Young Academic Urologists (EAU-YAU, Amsterdam, Netherlands. jeremyteoh@surgery.cuhk.edu.hk $1 https://orcid.org/0000000293612342
245    10
$a En bloc resection of bladder tumour: the rebirth of past through reminiscence / $c JY. Teoh, D. D'Andrea, A. Gallioli, T. Yanagisawa, S. MacLennan, R. Nicoletti, NC. Fai, D. Maffei, R. Hurle, L. Lusuardi, B. Malavaud, J. Miki, M. Kramer, H. Mostafid, D. Enikeev, M. Babjuk, A. Breda, S. Shariat, P. Gontero, T. Herrmann
520    9_
$a PURPOSE: To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer. METHODS: In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT. RESULTS: Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting. CONCLUSION: ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.
650    _2
$a lidé $7 D006801
650    _2
$a cystektomie $x metody $7 D015653
650    _2
$a močový měchýř $x patologie $7 D001743
650    12
$a nádory močového měchýře $x chirurgie $x patologie $7 D001749
650    _2
$a metaanalýza jako téma $7 D015201
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a D'Andrea, David $u Urothelial Cancer Working Group, European Association of Urology-Young Academic Urologists (EAU-YAU, Amsterdam, Netherlands $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
700    1_
$a Gallioli, Andrea $u Urothelial Cancer Working Group, European Association of Urology-Young Academic Urologists (EAU-YAU, Amsterdam, Netherlands $u Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain
700    1_
$a Yanagisawa, Takafumi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
700    1_
$a MacLennan, Steven $u Academic Urology Unit, University of Aberdeen, Aberdeen, UK
700    1_
$a Nicoletti, Rossella $u Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China $u Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy
700    1_
$a Fai, Ng Chi $u Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China
700    1_
$a Maffei, Davide $u Department of Urology, University College London Hospital NHS Foundation Trust, London, UK $u Department of Biomedical Sciences, Humanitas University, Milan, Italy
700    1_
$a Hurle, Rodolfo $u Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy
700    1_
$a Lusuardi, Lukas $u Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020, Salzburg, Austria
700    1_
$a Malavaud, Bernard $u Institut Universitaire du Cancer Toulouse-Oncopôle, Toulouse, France
700    1_
$a Miki, Jun $u Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
700    1_
$a Kramer, Mario $u Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany
700    1_
$a Mostafid, Hugh $u Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK
700    1_
$a Enikeev, Dmitry $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
700    1_
$a Babjuk, Marek $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic
700    1_
$a Breda, Alberto $u Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain
700    1_
$a Shariat, Shahrokh $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia $u Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic $u Department of Urology, Weill Cornell Medical College, New York, NY, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX, USA $u Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan
700    1_
$a Gontero, Paolo $u Department of Urology, Città Della Salute e Della Scienza, University of Torino School of Medicine, Turin, Italy
700    1_
$a Herrmann, Thomas $u Department of Urology, Kantonsspital Frauenfeld, Frauenfeld, Switzerland
773    0_
$w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 41, č. 10 (2023), s. 2599-2606
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37584691 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213094408 $b ABA008
999    __
$a ok $b bmc $g 2049642 $s 1210854
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 41 $c 10 $d 2599-2606 $e 20230816 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...